Abiopharma

🔍 Xie Ken (Executive)

Company: Fortinet, Inc. (FTNT)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 6,260 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 52,983,138.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 4,557 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 52,987,695.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 2,275 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 52,989,970.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 6,611 shares of Common Stock at $86.29 per share (Direct)
  Date: 2026-05-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 52,983,359.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 410 shares of Common Stock at $87.0417 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 52,982,949.00 | transaction_form_type: 4 | Footnotes: F3, F4
• Sold 425 shares of Common Stock at $88.0878 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 52,982,524.00 | transaction_form_type: 4 | Footnotes: F3, F5
• Sold 4,383 shares of Common Stock at $89.1247 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 52,978,141.00 | transaction_form_type: 4 | Footnotes: F3, F6
• Sold 137 shares of Common Stock at $89.6107 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 52,978,004.00 | transaction_form_type: 4 | Footnotes: F3, F7
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: By Spouse | shares_owned_after: 4,848,774.00
• Sold 6,260 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 18,780.00 | transaction_form_type: 4 | Footnotes: F8, F1, F9, F10
• Sold 4,557 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 31,904.00 | transaction_form_type: 4 | Footnotes: F8, F1, F11, F10
• Sold 2,275 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 25,029.00 | transaction_form_type: 4 | Footnotes: F8, F1, F12, F10

Footnotes:

• F1: Vesting of restricted stock units ("RSUs") previously granted to the Reporting Person.
• F2: Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units.
• F3: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 9, 2024.
• F4: Represents the weighted average sale price. The lowest price at which shares were sold was $86.51 and the highest price at which shares were sold was $87.48. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the ranges set forth in footnotes (4), (5), (6) and (7) to this Form 4.
• F5: Represents the weighted average sale price. The lowest price at which shares were sold was $87.52 and the highest price at which shares were sold was $88.515.
• F6: Represents the weighted average sale price. The lowest price at which shares were sold was $88.52 and the highest price at which shares were sold was $89.51.
• F7: Represents the weighted average sale price. The lowest price at which shares were sold was $89.52 and the highest price at which shares were sold was $89.70.
• F8: Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement.
• F9: 25% of the RSUs vested on February 1, 2024, and the remaining 75% of the RSUs will vest in equal installments on each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon settlement.
• F10: RSUs do not expire; they either vest or are canceled prior to the vesting date.
• F11: 25% of the RSUs vested on February 1, 2025, and the remaining 75% of the RSUs will vest in equal installments on each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon settlement.
• F12: 25% of the RSUs vested on February 1, 2026, and the remaining 75% of the RSUs will vest in equal installments on each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting.